Source: Annual Congress 2010 - Influenza A (H1N1) and other viral infections: therapeutic aspects
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
G. Semenkova, Y. Sudnik, M. Petukh, T. Kulahava, O. Savinova (Minsk, Belarus). Modification of phagocyte redox systems by influenza A virus. Eur Respir J 2010; 36: Suppl. 54, 2991

Member's Comments

No comment yet.

Related content which might interest you: Monitoring the kinetics of a vaccine-induced T-cell response after H1N1 influenza vaccination Source: Annual Congress 2010 - Influenza A (H1N1) and other viral infections: therapeutic aspects Year: 2010 Immunological responses to influenza infection Source: Annual Congress 2006 - Influenza: from avian flu to pandemia? Year: 2006 Role of reactive persulfide species in influenza virus-induced lung inflammation in mice Source: Virtual Congress 2020 – Translational science in respiratory infections Year: 2020 Impact of the COVID-19 pandemic on Influenza virus transmission Source: Virtual Congress 2021 – COVID - 19: lessons learned Year: 2021 Emergence of an immunosuppressive neutrophil phenotype during pneumococcal lung co-infection with influenza A virus Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations Year: 2019 Acutely lethal H1N1 influenza A virus infection alters the murine alveolar type II cell surfactant lipidome Source: International Congress 2016 – Viral infections in different respiratory conditions: from the bedside to the lab Year: 2016 Assessment of the association between asthma and immune responses to measles and mumps vaccine viruses Source: Annual Congress 2008 - Novel therapeutic approaches and immunological mechanisms in airway cell pathobiology Year: 2008 Role of influenza virus infection in lung fibrosis Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease Year: 2010 LSC Abstract – The expression and function of BPIFA1 in the pulmonary innate immune response to influenza A virus infection Source: International Congress 2015 – Viral infections: basic research and clinical perspective Year: 2015 Tropism and innate host responses of influenza A/H5N6 virus: an analysis of ex vivo and in vitro cultures of the human respiratory tract Source: Eur Respir J , 49 (3) 1601710; DOI: 10.1183/13993003.01710-2016 Year: 2017 Protective efficacy of virus like particles (VLPs) containing the influenza HA and/or NA in a murine model of postinfluenza bacterial pneumonia Source: Virtual Congress 2020 – Translational science in respiratory infections Year: 2020 Possible mechanism of immunopathological damage induced by hemagglutinin protein of H5N1 Source: Annual Congress 2009 - Mechanisms of pulmonary inflammation and fibrosis Year: 2009 An innate defence role for BPIFA1/SPLUNC1 against influenza-A virus infection Source: International Congress 2015 – The multiple faces of host defense Year: 2015 Investigation of the innate antiviral response to respiratory syncytial virus Source: International Congress 2015 – Paediatric pulmonary infections: mechanisms and treatment Year: 2015 Clinical relevance of mixed respiratory viral infections in adults with influenza A H1N1 Source: Eur Respir J 2011; 38: 739-742 Year: 2011 Assessment of humoral and cell-mediated immune response to measles mumps rubella vaccine viruses among patients with asthma Source: Annual Congress 2010 - Clinical aspects of asthma and allergic respiratory diseases Year: 2010 Influenza infection of monocyte-macrophages is insensitive to inhibition by NH4Cl Source: Annual Congress 2009 - Viruses and respiratory infections: prevalence and mechanisms of infection Year: 2009 Human immune recognition-based multicomponent subunit vaccines against tuberculosis Source: Eur Respir J 2005; 25: 902-910 Year: 2005 PP230 – Functional profiling and visualization of stromal cell dynamics in the influenza virus infected lung Source: ERS Lung Science Conference 2021 Year: 2021